“I have worked with Synterex for several years at 2 different small pharma companies. Jeanette and her team provided expert guidance and support for several regulatory submissions, including an NDA and MAA. Most recently they prepared a Phase 2 protocol and 2 IBs and DSURs, enabling us to push forward our key programs. The Synterex team is very knowledgeable and responsive and work well with our internal development team. I continue to rely on their support and highly recommend them to my industry colleagues.”

-John McCartney, PhD, Head of Medical Writing, Verastem Oncology

"Synterex has been a key factor in our recent success through their provision of consistent medical writing and project management expertise. We appreciate their reliability, creativity and ability to deliver major global submissions. Their agility in the face of shifting scope and timelines, and their professionalism and positive demeanor overall, have supported successful regulatory filings leading to drug approval. As a result we have expanded our portfolio of global submission documents outsourced to them."

- Director, Medical Writing, mid-sized biopharmaceutical company

"Synterex led the development of a clinical study report for our company, providing valuable guidance on structure and approach in addition to clear, effective process management."

- Director of Medical Writing, gene therapy-focused biotech company